No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study-Reference-Cited by-同舟云学术

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Ascierto Paolo A.¹^ORCID,Marincola Francesco M.²,Fox Bernard A.³⁴,Galon Jérôme⁵⁶⁷^ORCID

Affiliation:

1. Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS Fondazione “G. Pascale”, Napoli, Italy

2. Refuge Biotechnologies, Menlo Park, CA, USA

3. Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA

4. Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA

5. Laboratory of Integrative Cancer Immunology, INSERM, Paris, France

6. Equipe Labellisée Ligue Contre le Cancer, Paris, France

7. Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France

Funder

INSERM

the LabEx Immuno-oncology

the Transcan ERAnet European project

the Society for Immunotherapy of Cancer

Association pour la Recherche contre le Cancer

CARPEM, AP-HP

HalioDx

Institut National du Cancer, France